SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Mannatech, Inc. engages in the development of nutritional supplements, topical and skin care products and weight-management products that target optimal health and wellness. Its product category includes integrative health, targeted health, wealth and fitness, skin care, essentials, and home. The company was founded by Marlin Ray Robbins and Samuel L. Caster in November 1993 and is headquartered in Flower Mound, TX.

Mannatech Inc

Mannatech ($MTEX) is experiencing heightened interest following a substantial surge in trading volume, with community members aggressively speculating on a potential low-float short squeeze. Discussions are centered on its micro-cap status and the possibility of a multi-day parabolic run, drawing comparisons to other recent volatile movers, though some express caution regarding a potential pump and dump.

Innodata, Inc. is a data engineering company, which engages in providing artificial intelligence software platforms and management of its services. It operates through the following business segments: Digital Data Solutions (DDS), Synodex, and Agility. The DDS segment combines deep neural networks and human expertise in multiple domains to make unstructured information useable. The Synodex segment enables clients in the insurance and healthcare sectors to transform medical records into useable digital data and to apply technologies to the digital data to augment decision support. The Agility segment provides tools and related professional services that enable public relations and communications professionals to discover influencers, amplify messages, monitor coverage, and measure the impact of campaigns. The company was founded by Todd H. Solomon in 1988 and is headquartered in Ridgefield Park, NJ.

Innodata Inc

Innodata Inc. is currently trending as investors eagerly anticipate a joint press release detailing a significant new partnership for its Federal unit, an announcement the company has indicated is forthcoming. Community discussions are rife with speculation over the partner's identity and the potential for a short squeeze, underscoring Innodata's strategic expansion into government and military AI data training as a key long-term growth driver.

Ekso Bionics Holdings, Inc. engages in the provision of design, development, and sale of exoskeleton technology that currently has applications in healthcare and industrial markets. The company was founded on January 30, 2012 and is headquartered in San Rafael, CA.

Ekso Bionics Holdings Inc

Ekso Bionics is trending following a proposed merger with Applied Digital's cloud computing business to create ChronoScale, an accelerated GPU compute platform for AI workloads. This strategic shift from medical hardware to the rapidly expanding AI infrastructure sector is generating significant community discussion, with many envisioning a complete valuation framework change and others cautious about the implications for existing shareholders.

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

Greenwich LifeSciences Inc

Greenwich LifeSciences (GLSI) is trending due to compelling preliminary Phase 3 data showing a significant reduction in breast cancer recurrence rates and a strategic extension of insider share lock-ups through September 2026. The community is actively discussing a potential short squeeze, fueled by the stock's low float, extremely high cost-to-borrow rates, and substantial trading volume, with many anticipating significant long-term gains and potential acquisition interest for its promising GLSI-100 immunotherapy.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Eli Lilly is trending as its innovative pipeline continues to impress, with positive trial data for its next-generation obesity drug, retatrutide, and high anticipation for its oral GLP-1, orforglipron. The community is actively debating LLY's market leadership against fierce competition in the rapidly expanding weight-loss sector, with strong bullish sentiment contrasted by concerns over valuation and the competitive landscape. This ongoing innovation and strategic manufacturing expansion are cementing its role as a pharmaceutical giant.

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

AMGEN Inc.

Amgen is trending with significant pipeline news, including positive Phase 2 results for its obesity drug MariTide, which showed strong weight loss but also prompted community discussion around tolerability and potential dosing adjustments. Further boosting its portfolio, the company recently reported successful Phase 3 data for its Repatha cholesterol drug, alongside new FDA approvals for therapies in generalized myasthenia gravis and lung cancer, all while strategically engaging on U.S. drug pricing.

Roundhill ETF Trust - Roundhill GLP-1 & Weight Loss ETF

Roundhill GLP-1 & Weight Loss ETF

The Roundhill GLP-1 & Weight Loss ETF ($OZEM) is drawing significant attention as the therapeutic scope for GLP-1 drugs rapidly expands beyond obesity, with recent regulatory milestones for new indications fueling optimism. Investors are actively discussing the potential for increased insurance coverage and the long-term growth trajectory of this innovative sector, despite ongoing competitive dynamics.

Global X Funds - Global X Uranium ETF

Global X Uranium ETF

The Global X Uranium ETF is trending as the community increasingly links burgeoning AI energy demand to a critical need for stable nuclear power, solidifying uranium's strategic resource status. Investors are actively discussing the recent inclusion of uranium on the U.S. critical minerals list and a persistent supply deficit, further amplified by continuous buying from investment vehicles and supportive government policies. This confluence of factors underpins a strong long-term bullish outlook for the sector.

Solidion Technology, Inc. engages in researching, developing and manufacturing battery components and materials, batteries and related energy storage products for the automotive electric vehicle and other markets. The company was founded on June 30, 2023 and is headquartered in Dallas, TX.

Solidion Technology Inc

Solidion Technology ($STI) is trending following news of a second grant from the U.S. Department of Energy for advanced nuclear materials and its work on uninterruptible power supply systems for AI data centers. The community is actively discussing a potential short squeeze fueled by a very low share float and high borrow rates, alongside the perceived value of its advanced battery technology. Many traders are anticipating significant upside, closely watching for further developments in the company's innovative applications within critical energy sectors.

Intelligent Living Application Group, Inc. engages in the manufacturing and selling of mechanical locksets. It focuses in producing mechanical locksets including locksets for outdoors such as main entrances and gates and indoors. The firm offers a range of original design manufacturer door locksets to various customer segments with classic to contemporary looks, functions and colors. The company was founded by Po Wang Hui in 1981 and is headquartered in Hong Kong.

Intelligent Living Application Group Inc

Intelligent Living Application Group is trending following strong revenue and gross profit growth reported in its latest financials, along with recent product launches in the smart lock market. Community discussion emphasizes the stock's potential for a significant upward move, drawing comparisons to other volatile Chinese and Hong Kong micro-cap names known for explosive price action and speculating on a potential short squeeze and active accumulation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Ayala Pharmaceuticals, Inc. is a clinical-stage oncology company, which engages in developing and commercializing small molecule therapeutics for patients suffering from rare tumors and aggressive cancers. Its lead candidates are the oral gamma secretase inhibitor, AL102, for desmoid tumors, and aspacytarabine (BST-236), a novel proprietary anti-metabolite for first line treatment in unfit acute myeloid leukemia. The company was founded on June 5, 1987 and is headquartered in Monmouth Junction, NJ.

ADXS
Advaxis, Inc.

Feed

News

Sentiment

Fundamentals

Info

Latest ADXS News

ADXSAdvaxis, Inc.